Emergent Biosolutions: Q4 Earnings Snapshot

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Monday reported a fourth-quarter loss of $88 million, after reporting a profit in the same period a year earlier.

On a per-share basis, the Gaithersburg, Maryland-based company said it had a loss of $1.76. Losses, adjusted for non-recurring costs, were 31 cents per share.

The biopharmaceutical company posted revenue of $330.7 million in the period.

For the year, the company reported a loss of $223.8 million, or $4.47 per share, swinging to a loss in the period. Revenue was reported as $1.12 billion.

Emergent Biosolutions expects full-year revenue of $1.15 billion.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EBS at https://www.zacks.com/ap/EBS

Copyright © 2023 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.

More from WTOP

Log in to your WTOP account for notifications and alerts customized for you.

Sign up